跳至主要内容
临床试验/NCT04316338
NCT04316338撤回不适用

Intermittent Theta-Burst Stimulation to Target Irritability in Adults With ASD

Stanford University0 个研究点开始时间: 2022年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
Aberrant Behavior Checklist-irritability subscale (ABC-I)

研究概览

简要总结

This study aims to demonstrate the feasibility, tolerability, safety and preliminary efficacy of 6 weeks of fMRI-guided iTBS delivered to personalized regions of the prefrontal cortex (PFC) in adults with ASD in reducing irritability in adults with ASD.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
22 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of ASD or Asperger's based on DSM-5 criteria as confirmed by a qualified clinician (including Dr. Fung), and if necessary the administration of Autism Diagnostic Interview-Revised (ADI-R) and/or Autism Diagnostic Observation Schedule-Generic (ADOS-G)
  • Adults who are physically healthy.
  • No significant current psychosocial stressors per history.
  • Full scale IQ >
  • ABC-I score of 18 or greater.
  • if the participant is taking medication, they must be stable on this medication regiment for at least 4 weeks prior to baseline and agree to stay on these medications for the duration of the trial

排除标准

  • (f) Pre-term birth (<34 weeks' gestation) (g) Low birth weight (<2000 g). (h) DSM-5 diagnosis of other severe psychiatric disorder such as bipolar disorder or schizophrenia.
  • (i) Current use of benzodiazepines. (j) Use of other medications that modulate the GABA(A) receptor within 4 weeks of scanning (8 weeks for fluoxetine).
  • (k) History of alcoholism or substance abuse. (l) Active medical problems such as unstable seizures, congenital heart disease, endocrine disorders.
  • (m) Significant sensory impairments such as blindness or deafness. (n) Contraindication for MRI. (o) Pregnancy. (p) evidence of genetic syndrome.

结局指标

主要结局

Aberrant Behavior Checklist-irritability subscale (ABC-I)

时间窗: Change across time: Baseline minus immediately after final treatment

A parent/caregiver/clinician completed checklist (58-item) with an irritability subscale (15-item). Each item has a maximum score of 3, meaning that the irritability subscale has a maximum score of 45 and minimum score of 0. Higher scores indicate higher levels of irritability.

次要结局

  • Self-injury questionnaire (SIQ)(Baseline, immediately after treatment, one month after treatment.)
  • THE MODIFIED OVERT AGGRESSION SCALE (MOAS)(Baseline, immediately after treatment, one month after treatment.)
  • Difficulties in Emotion Regulation Scale(Baseline, immediately after treatment, one month after treatment.)
  • Montgomery-Åsberg Depression Rating Scale (MADRS)(Baseline, immediately after treatment, one month after treatment.)
  • Repetitive Behavior Scale-Revised (RBS-R)(Baseline, immediately after treatment, one month after treatment.)
  • Functional connectivity between areas involved in negative emotion regulation(Baseline, immediately after treatment, one month after treatment.)
  • EEG recordings(Baseline, immediately after treatment, one month after treatment.)
  • Aberrant Behavior Checklist-irritability subscale (ABC-I)(Change across time: Baseline minus one month after treatment)
  • Irritability Questionnaire(Baseline, every week of treatment (1-6), immediately after treatment, one month after treatment.)
  • The Adult Autism Quotient (AQ)(Baseline, immediately after treatment, one month after treatment.)
  • Magnetic resonance spectroscopy (MRS)(Baseline, immediately after treatment, one month after treatment.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lawrence Fung

Assistant Professor

Stanford University

相似试验